Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib and Celecoxib Chemoprevention in Head and Neck Premalignant Lesions
NCT00314262Phase 2Completed
- Sponsor
- Emory University
- Start
- Oct 2006
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in Precancerous lesion, sponsored by Emory University. Started Oct 2006; status: completed.
02
Drugs
erlotinib
03
Conditions
Precancerous lesion
Beyond the preview
Go deeper on NCT00314262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314262.